en

PRODUCT DETAIL

Pamifos

Code 99825
MA number 44/0199/06-S
Product Form: con inf 4x5 ml/15 mg (liek.inj.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
Therapeutic Class: 44 - CYTOSTATICA
ATC:
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BA Bisphosphonates
M05BA03 Pamidronic acid
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10a well-established use application
MA issued: 11.05.2006
Pediatric warnings: Yes
PIL: PIL_Pamifos_05/2019.Doc.doc  
SPC: SPC_Pamifos_05/2019.doc.doc  
Safety feature Yes
Data update: 29.05.2019
eu-flag.png sk-flag.png